Wang Hai-Bo, Fang Gang, Yu Wen-Zhou, Du Fei, Fan Chun-Xiang, Liu Qing-Lian, Hao Li-Xin, Liu Yu, Zheng Jing-Shan, Qin Zhi-Ying, Xia Wei, Zhang Shi-Yue, Yin Zun-Dong, Jing Qiong, Zhang Yan-Xia, Huang Rong-Na, Yang Ru-Pei, Tong Wen-Bin, Qi Qi, Guan Xu-Jing, Jing Yu-Lin, Ma Qian-Li, Wang Jin, Ma Xiao-Zhen, Chen Na, Zheng Hong-Ru, Li Yin-Qiao, Ma Chao, Su Qi-Ru, Reilly Kathleen H, Luo Hui-Ming, Wu Xian-Ping, Wen Ning, Yang Wei-Zhong
Chinese Center for Disease Control and Prevention, Nanwei Rd 27#, Xicheng District, Beijing 100050, PR China; Peking University Clinical Research Institute, Xueyuan Rd 38#, Haidian District, Beijing 100191, PR China.
Sichuan Provincial Center for Disease Control and Prevention, Zhongxue Road 6#, Chengdu City, Sichuan Province 610041, PR China.
PLoS One. 2014 Dec 11;9(12):e113880. doi: 10.1371/journal.pone.0113880. eCollection 2014.
During August 2011-February 2012, an outbreak of type Π circulating vaccine-derived poliovirus (cVDPVs) occurred in Sichuan Province, China.
A field investigation of the outbreak was conducted to characterize outbreak isolates and to guide emergency response. Sequence analysis of poliovirus capsid protein VP1 was performed to determine the viral propagation, and a coverage survey was carried out for risk assessment.
One clinical compatible polio case and three VDPV cases were determined in Ngawa County, Ngawa Tibetan and Qiang Autonomous Prefecture, Sichuan Province. Case patients were unimmunized children, 0.8-1 years old. Genetic sequencing showed that the isolates diverged from the VP1 region of the type Π Sabin strain by 5-12 nucleotides (nt) and shared the same 5 nt VP1 substitutions, which indicate single lineage of cVDPVs. Of the 7 acute flaccid paralysis cases (all>6 months) reported in Ngawa Prefecture in 2011, 4 (57.1%) cases (including 2 polio cases) did not receive oral attenuated poliovirus vaccine. Supplementary immunization activities (SIAs) were conducted in February-May, 2012, and the strain has not been isolated since.
High coverage of routine immunization should be maintained among children until WPV transmission is globally eradicated. Risk assessments should be conducted regularly to pinpoint high risk areas or subpopulations, with SIAs developed if necessary.
2011年8月至2012年2月期间,中国四川省发生了Ⅱ型循环疫苗衍生脊髓灰质炎病毒(cVDPVs)疫情。
对此次疫情进行了现场调查,以鉴定疫情分离株并指导应急响应。对脊髓灰质炎病毒衣壳蛋白VP1进行序列分析以确定病毒传播情况,并开展了覆盖率调查以进行风险评估。
在四川省阿坝藏族羌族自治州阿坝县确定了1例临床符合脊髓灰质炎病例和3例VDPV病例。病例患者为未接种疫苗的儿童,年龄在0.8至1岁之间。基因测序显示,分离株与Ⅱ型萨宾株的VP1区域有5至12个核苷酸(nt)的差异,并共有相同的5个nt的VP1替换,这表明为单一谱系的cVDPVs。2011年阿坝州报告的7例急性弛缓性麻痹病例(均>6个月)中,4例(57.1%)病例(包括2例脊髓灰质炎病例)未接种口服脊髓灰质炎减毒活疫苗。2012年2月至5月开展了补充免疫活动(SIAs),此后未再分离到该毒株。
在全球根除野生脊灰病毒传播之前,应保持儿童常规免疫的高覆盖率。应定期进行风险评估,以确定高风险地区或亚人群,必要时开展补充免疫活动。